InviCRO LLC:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:InviCRO LLC - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C10491
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:30
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
InviCRO LLC (InviCRO) a subsidiary of Konica Minolta Inc, is a provider of image informatics, engineering and operational services in translational drug discovery and development. The company developed VivoQuant, a DICOM compliant post-processing suite for image data combining fundamental visualization with analysis capabilities; and iPACS, a full image study data management platform that allows management, distribution, analysis, and presentation of images and data associated with studies. InviCRO offers solutions in the areas of clinical imaging, radio and medicinal chemistry, nonclinical imaging, analytics, histology and tissue imaging, and data management. The company has operations with clinical facility in Connecticut, the US; and London, the UK. InviCRO is headquartered in Boston, Massachusetts, the US.

InviCRO LLC – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
InviCRO LLC, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
InviCRO LLC, Medical Equipment Deals By Type, 2012 to YTD 2018 6
InviCRO LLC, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
InviCRO LLC, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
InviCRO LLC, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
InviCRO LLC, Medical Equipment, Deal Details 10
Venture Financing 10
inviCRO Raises USD45.8 Million in Financing Round 10
Partnerships 11
Enigma Biomedical and Invicro to Enter into Co-Development Agreement 11
Enigma Biomedical Enters into Collaboration Agreement with Invicro 12
Bioverativ and Invicro Enter into Agreement 13
Acquisition 14
inviCRO Acquires CORE Clinical 14
Konica Minolta Acquires inviCRO 15
inviCRO Acquires Molecular NeuroImaging 16
InviCRO LLC – Key Competitors 17
InviCRO LLC – Key Employees 18
InviCRO LLC – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 20
Corporate Communications 20
Aug 02, 2018: Invicro names Dr. Brian Avants as senior director of machine learning 20
Jul 19, 2018: Invicro scientists awarded Alavi-Mandell Publication Award and named finalist for the Ziskind-Somerfeld Research Award 21
May 02, 2018: Invicro Hires Peter Genakos as New Haven’s General Manager 22
Feb 27, 2018: Invicro Hires Edward Hogan as Senior Vice President of Clinical Operations 23
Feb 20, 2018: Invicro Names George Abe as Senior Vice President, Pathology 24
Other Significant Developments 25
Feb 21, 2018: Invicro becomes the latest industry partner to join Dementias Platform UK 25
Jan 31, 2018: Ambry Genetics and Invicro Announce Partnership to Provide Enhanced Capabilities with Advanced Genomics Services to Enable Precision Medicine 26
Aug 24, 2017: Bioverativ and Invicro Form Novel, Advanced Imaging Collaboration Focused on Improving Management of Joint Health in People with Hemophilia 27
Jul 11, 2017: Mind maps – scanning completed on the first participants 28
Jan 18, 2017: Magnetic Insight Signs Agreement with inviCRO to Support Imaging Analysis Tools for Quantitative Magnetic Particle Imaging 29
Appendix 30
Methodology 30
About GlobalData 30
Contact Us 30
Disclaimer 30

List of Tables
InviCRO LLC, Medical Equipment, Key Facts 2
InviCRO LLC, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
InviCRO LLC, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
InviCRO LLC, Medical Equipment Deals By Type, 2012 to YTD 2018 6
InviCRO LLC, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
InviCRO LLC, Deals By Market, 2012 to YTD 2018 8
InviCRO LLC, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
inviCRO Raises USD45.8 Million in Financing Round 10
Enigma Biomedical and Invicro to Enter into Co-Development Agreement 11
Enigma Biomedical Enters into Collaboration Agreement with Invicro 12
Bioverativ and Invicro Enter into Agreement 13
inviCRO Acquires CORE Clinical 14
Konica Minolta Acquires inviCRO 15
inviCRO Acquires Molecular NeuroImaging 16
InviCRO LLC, Key Competitors 17
InviCRO LLC, Key Employees 18
InviCRO LLC, Other Locations 19
InviCRO LLC, Subsidiaries 19

List of Figures
InviCRO LLC, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
InviCRO LLC, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
InviCRO LLC, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
InviCRO LLC, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
InviCRO LLC, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
InviCRO LLC, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
InviCRO LLC, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
InviCRO LLC, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[InviCRO LLC:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Universal Health Services Inc (UHS):企業の財務・戦略的SWOT分析
    Universal Health Services Inc (UHS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Specialist Investment Properties PLC:企業の戦略・SWOT・財務分析
    Specialist Investment Properties PLC - Strategy, SWOT and Corporate Finance Report Summary Specialist Investment Properties PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • NXP Semiconductors NV (NXPI):企業の財務・戦略的SWOT分析
    NXP Semiconductors NV (NXPI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • XenoPort Inc-製薬・医療分野:企業M&A・提携分析
    Summary XenoPort Inc (XenoPort) is a bio-pharmaceutical company which develops and commercializes internally discovered product candidates for the treatment of neurological disorders. It develops Transported Prodrugs through the modification of chemical structure of existing drugs in the market. The …
  • Lloyds Banking Group Plc:企業の戦略・SWOT・財務分析
    Lloyds Banking Group Plc - Strategy, SWOT and Corporate Finance Report Summary Lloyds Banking Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Mutuelle Generale de l’Education Nationale:企業の戦略的SWOT分析
    Mutuelle Generale de l'Education Nationale - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors an …
  • ICICI Prudential Life Insurance Company Limited:企業の戦略・SWOT・財務情報
    ICICI Prudential Life Insurance Company Limited - Strategy, SWOT and Corporate Finance Report Summary ICICI Prudential Life Insurance Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, o …
  • Sibur Holding:企業の戦略的SWOT分析
    Sibur Holding - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • KLA-Tencor Corporation:企業の戦略・SWOT・財務分析
    KLA-Tencor Corporation - Strategy, SWOT and Corporate Finance Report Summary KLA-Tencor Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Saudi Arabian Oil Co (2222):企業の財務・戦略的SWOT分析
    Saudi Arabian Oil Co (2222) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Mitsubishi Chemical Holdings Corp (4188):企業の財務・戦略的SWOT分析
    Mitsubishi Chemical Holdings Corp (4188) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Ipsen SA (IPN):製薬・医療:M&Aディール及び事業提携情報
    Summary Ipsen SA (Ipsen) is a global specialty biopharmaceutical company that manufactures and distributes drugs for the treatment of cancer and rare and neurological diseases. The company develops and commercializes novel medicines in cancer, neuroscience and rare diseases. It also offers products …
  • Enbridge Inc (ENB):企業の財務・戦略的SWOT分析
    Enbridge Inc (ENB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • SmarTone Mobile Communications Ltd:企業の戦略的SWOT分析
    SmarTone Mobile Communications Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Thornton & Ross Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Thornton & Ross Ltd (Thornton & Ross), a subsidiary of Stada Arzneimittel AG is a supplier of medicines and healthcare products. The company offers over the counter pharmaceutical products. It also manufactures pharmaceutical creams, liquids and semi-solids. Thornton & Ross’ products compris …
  • Marafiq:発電所・企業SWOT分析
    Marafiq - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executives …
  • Power Climber Wind:企業の戦略的SWOT分析
    Power Climber Wind - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • ALK-Abello AS (ALK B)-製薬・医療分野:企業M&A・提携分析
    Summary ALK-Abello A/S (ALK) is a research-oriented pharmaceutical company, which discovers, develops and commercializes immunotherapies for allergy prevention and treatment. It also markets diagnostics and other services to allergy clinics. The company's allergy immunotherapy product portfolio incl …
  • National Power Corp:企業の戦略的SWOT分析
    National Power Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Biotest AG (BIO):企業の財務・戦略的SWOT分析
    Biotest AG (BIO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆